0000897069-18-000366.txt : 20180516 0000897069-18-000366.hdr.sgml : 20180516 20180516100118 ACCESSION NUMBER: 0000897069-18-000366 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20180516 DATE AS OF CHANGE: 20180516 EFFECTIVENESS DATE: 20180516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312505 FILM NUMBER: 18839042 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 D 1 primary_doc.xml X0708 D LIVE 0001533743 Processa Pharmaceuticals, Inc. 7380 COCA COLA DRIVE SUITE 106 HANOVER MD MARYLAND 21076 443-776-3133 DELAWARE Heatwurx, Inc. Corporation true David Young 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Director Patrick Lin 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Director Justin W. Yorke 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Director Virgil Thompson 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Director Sian Bigora 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Helen Pentikis 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Wendy Guy 7380 Coca Cola Drive Suite 106 Hanover MD MARYLAND 21076 Executive Officer Pharmaceuticals Decline to Disclose 06c false 2018-05-15 false true true false 0 Boustead Securities, LLC 141391 None None 6 Venture Suite 325 Irvine CA CALIFORNIA 92618 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA IA IOWA LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NV NEVADA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WI WISCONSIN false Fintech Clearing, LLC 134742 None None 6 Venture Suite 325 Irvine CA CALIFORNIA 92618 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING false 8000000 2525694 5474306 If the warrants are exercised, the issuer may raise up to an additional $9,600,000. false 33 480000 0 The Sales Commissions are based on Total Offering Amount being raised. 0 false Processa Pharmaceuticals, Inc. David Young David Young Chief Executive Officer 2018-05-15